Optimization of biopolymer based transdermal films of metoclopramide as an alternative delivery approach

Polymers

Volumn 6, Issue 5, 2014, Pages 1350-1365

  Aktar, Betül ^a   Erdal, Meryem Sedef ^a   Sagirli, Olcay ^a   Güngör, Sevgi ^a   Özsoy, Yildiz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antiemetic drug; Metoclopramide; Natural polymers; Sodium alginate; Terpenes; Transdermal film

Indexed keywords

FOURIER TRANSFORM INFRARED SPECTROSCOPY; LIPID BILAYERS; NATURAL POLYMERS; PATIENT TREATMENT; TERPENES;

ANTIEMETIC DRUG; ATTENUATED TOTAL REFLECTANCE INFRARED; BIO ADHESIVES; METOCLOPRAMIDE; PATIENT COMPLIANCE; PERMEATION ENHANCEMENT; STRATUM CORNEUM; TRANSDERMAL;

SODIUM ALGINATE;

EID: 84901983982     PISSN: None     EISSN: 20734360     Source Type: Journal    
DOI: 10.3390/polym6051350     Document Type: Article

References (53)

1. Pillai, O.; Panchagnula, R. Polymers in drug delivery. Curr. Opin. Chem. Biol. 2001, 5, 447-451.
2. Erdal, M.S.; Güngör, S.; Özsoy, Y. Biopolymers: Dermal and Transdermal Drug Delivery Systems. In Encyclopaedia of Biomedical Polymers and Polymeric Biomaterials; Mishra, M.K., Ed.; Taylor & Francis: New York, NY, USA, 2014, in press.
3. Güngör, S.; Bektaş, A.; Alp, F.I.; Uydeş-Doǧan, B.S.; Ozdemir, O.; Araman, A.; Özsoy, Y. Matrix-type transdermal patches of verapamil hydrochloride: In vitro permeation studies through excised rat skin and pharmacodynamic evaluation in rats. Pharm. Dev. Technol. 2008, 13, 283-289.
4. Can, S.; Erdal, M.S.; Güngör, S.; Özsoy, Y. Optimization and characterization of chitosan films for transdermal delivery of ondansetron. Molecules 2013, 18, 5455-5471.
5. Bektaş, A.; Cevher, E.; Güngör, S.; Özsoy, Y. Design and evaluation of polysaccharide-based transdermal films for the controlled delivery of nifedipine. Chem. Pharm. Bull. 2014, 6, 1-9.
6. Gruber, J.W. Polysaccharide based polymers in cosmetics. In Principles of Polymer Science and Technology in Cosmetics and Personal Care; Goddard, E.D., Gruber, J.V., Eds.; Marcel Dekker Inc.: New York, NY, USA, 1999; pp. 339-402.
7. Sinko, P.J.; Singh, Y. Martin's Physical Pharmacy and Pharmaceutical Sciences, 6th ed.; Wolters Kluwer: Baltimore, MD, USA; pp. 492-515.
8. Roy, S.K.; Prabhakar, B. Bioadhesive polymeric platforms for transmucosal drug delivery systems-A review. Trop. J. Pharm. Res. 2010, 9, 91-104.
9. Andersen, T.; Strand, B.L.; Formo, K.; Alsberg, E.; Christensen, B.E. Alginates as biomaterials in tissue engineering. Carbohydr. Chem. 2012, 37, 227-258.
10. Kitagawa, S.; Li, H.; Sato, S. Skin permeation of parabens in excised guinea pig dorsal skin, its modification by penetration enhancers and their relationship with n-octanol/water partition coefficients. Chem. Pharm. Bull. 1997, 45, 1354-1357.
11. Li, T.; Ren, C.; Wang, M.; Zhao, L.; Wang, X.; Fang, L. Optimized preparation and evaluation of indomethacin transdermal patch. Asian J. Pharm. Sci. 2007, 2, 249-259.
12. Krisnaiah, Y.S.R.; Raju, V.; Kumar, M.S.; Rama, B.; Raghumurthy, V.; Ramana Murthy, K.V. Studies on optimizing in vitro transdermal permeation of ondansetron hydrochloride using nerodilol, carvone, and limonene as penetration enhancers. Pharm. Dev. Technol. 2008, 13, 177-185.
13. Escobar-Chavez, J.J.; Quintanar-Guerrero, D.; Ganem-Quintanar, A. In vivo skin permeation of sodium naproxen formulated in pluronic F-127 gels: Effect of Azone and Transcutol. Drug Dev. Ind. Pharm. 2005, 31, 447-454.
14. Benson, H.A.E. Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv. 2005, 2, 23-33.
15. Levison, K.K.; Takayama, K.; Isowa, K.; Okabe, K.; Nagai, T. Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J. Pharm. Sci. 1994, 83, 1367-1372.
16. Aqil, M.; Ahad, A.; Sultana, Y.; Ali, A. Status of terpenes as skin penetration enhancers. Drug Discov. Today 2007, 12, 1061-1067.
17. Kang, L.; Yap, C.W.; Lim, P.F.C.; Chen, Y.Z.; Ho, P.C.; Chan, Y.W., Wong, G.P.; Chan, S.Y. Formulation development of transdermal dosage forms: Quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin. J. Control. Release 2007, 120, 211-219.
18. Rizwan, M.; Aqil, M.; Ahad, A.; Sultana, Y.; Ali, M.M. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev. Ind. Pharm. 2008, 34, 618-626.
19. Williams, A.C.; Edwards, H.G.M.; Lawson, E.E.; Barry, B.W. Molecular interactions between the penetration enhancer 1,8-cineole and human skin. J. Raman Spectrosc. 2006, 37, 361-366.
20. Babita, K.; Kumar, V.; Rana, V.; Jain, S.; Tiwory, A.K. Thermotropic and spectroscopic behavior of skin: Relationship with percutaneous permeation enhancement. Curr. Drug Deliv. 2006, 3, 95-113.
21. Chang, J.S.; Tsai, Y.H.; Wu, P.C.; Huang, Y.B. The effect of mixed-solvent and terpenes on percutaneous absorption of meloxicam gel. Drug Dev. Ind. Pharm. 2007, 33, 984-989.
22. Williams, A.C.; Barry, B.W. Terpenes and the lipid-protein partition theory of skin penetration enhancement. Pharm. Res. 1991, 8, 17-24.
23. Williams, A.C.; Barry, B.W. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int. J. Pharm. 1991, 74, 157-168.
24. Moghimi, H.R.; Williams, A.C.; Barry, B.W. Enhancement by terpenes of 5-fluororuracil permeation through the stratum corneum: model solvent approach. J. Pharm. Pharmacol. 1998, 50, 955-964.
25. Hori, M.; Satoh, S.; Maibach, H.I.; Guy, R.H. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: Effect of enhancer lipophilicity. J. Pharm. Sci. 1991, 80, 32-35.
26. Zaki, N.M.; Awaad, G.A.S.; Mortada, N.M.; Abd El Hady, S.S. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats. Int. J. Pharm. 2006, 327, 89-96.
27. Zaki, N.M.; Mortada, N.M.; Awaad, G.A.S.; Abd El Hady, S.S. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation. Int. J. Pharm. 2006, 327, 97-103.
28. Pitrè, D.; Stradi, R. Metoclopramide hydrochloride. In Analytical Profiles of Drug Substances, Florey, K., Ed.; Academic Press: San Diego, CA, USA, 1987; Volume 16, pp. 327-360.
29. Stosik, A.G.; Junginger, H.E.; Kopp, S.; Midha, K.K.; Shah, V.P.; Stavchansky, S.; Dressman, J.B.; Barends, D.M. Biowaiver monographs for immediate release solid oral dosage forms: Metoclopramide hydrochloride. J. Pharm. Sci. 2008, 97, 3700-3708.
30. Cevher, E.; Sensoy, D.; Taha, M.A.M. Effect of thiolated polymers to textural and mucoadhesive properties of vaginal gel formulations prepared with polycarbophil and chitosan. AAPS PharmSciTech 2008, 9, 953-965.
31. Jones, D.S.; Irwin, C.R.; Woolfson, A.D.; Djokic, J.; Adams, V. Physicochemical characterization and preliminary in vivo efficiacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis. J. Pharm. Sci. 1999, 88, 592-598.
32. Higuchi, T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52, 1145-1149.
33. Bommannan, D.; Potts, R.O.; Guy, R.H. Examination of stratum corneum barrier function in vivo by infrared spectroscopy. J. Investig. Dermatol. 1990, 95, 403-408.
34. Gorcea, M.; Hadgraft, J.; Moore, D.J.; Lane, M.E. In vivo barrier challenge and initial recovery in human facial skin. Skin Res. Technol. 2013, 19, e375-e382.
35. Baloǧlu, E.; Karavana, S.Y.; Hysein, I.Y.; Köse, T. Design and formulation of mebeverine HCl semisolid formulations for intraorally administration. AAPS PharmSciTech 2010, 11, 181-188.
36. Jones, D.S.; Woolfson, A.D.; Djokic, J.; Coulter, W.A. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm. Res. 1996, 13, 1734-1738.
37. Cevher, E.; Taha, M.A.M.; Orlu, M.; Araman, A. Evaluation of mechanical and mucoadhesive properties of clomiphene citrate gel formulations containing carbomers and their thiolated derivatives. Drug Deliv. 2008, 15, 57-67.
38. Jones, D.S.; Woolfson, A.D.; Brown, A.F.; O'Neill, M.J. Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: In vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J. Control. Release 1997, 49, 71-79.
39. The United States Pharmacopeia 31, 26th ed.; U.S. Pharmacopeial Convention: Twinbrook Parkway, Rockwille, MD, USA, 2008; p. 683.
40. Gutschke, E.; Bracht, S.; Nagel, S.; Weitschies, W. Adhesion testing of transdermal matrix patches with a probe tack test-In vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 2010, 75, 399-404.
41. Wokovich, A.M.; Prodduturi, S.; Doub, W.H.; Hussain, A.S.; Buhse, L.F. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur. J. Pharm. Biopharm. 2006, 64, 1-8.
42. Güngör, S.; Erdal, M.S.; Özsoy, Y. Plasticizers in Transdermal Drug Delivery Systems. In Recent Advances in Plasticizers; Luqman, M., Ed.; InTech: Rijeka, Croatia, 2012; pp. 91-112.
43. Costa, P.; Lobo, S.J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13, 123-133.
44. Bhatt, D.C.; Dhake, A.S.; Khar, R.K.; Mishra, D.N. Development and in vitro evaluation of transdermal matrix films of metoprolol tartrate. Yakugaku Zasshi. 2008, 128, 1325-1331.
45. Mamatha, T.; Venkateswara Rao, J.; Mukkanti, K.; Ramesh, G. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in vitro characterization. Daru. J. Pharm. Sci. 2010, 18, 9-16.
46. Tirunagari, M.; Jangala, V.R.; Khagga, M.; Gannu, R. Transdermal therapeutic system of isradipine: Effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics. Arch. Pharm. Res. 2010, 33, 1025-1033.
47. Melero, A.; Garrigues, T.M.; Almudever, P.; Villodre, A.M.; Lehr, C.M.; Schaefer, U. Nortriptyline hydrochloride skin absorption: Development of a transdermal patch. Eur. J. Pharm. Biopharm. 2008, 69, 588-596.
48. Zhao, K.; Singh, J. Mechanism(s) of in vitro percutaneous absorption enhancement of Tamoxifen by Enhancers. J. Pharm. Sci. 2000, 89, 771-780.
49. Levi, K.; Kwan, A.; Rhines, A.S.; Gorcea, M.; Moore, D.J.; Dauskardt, R.H. Emollient molecule effects on the drying stresses in human stratum corneum. Br. J. Dermatol. 2010, 163, 695-703.
50. Erdal, M.S.; Peköz Yi{dotless}ldi{dotless}z, A.; Aksu, B.; Araman, A. Impacts of chemical enhancers on skin permeation and deposition of terbinafine. Pharm. Dev. Technol. 2014, 19, 565-570.
51. Zhao, K.; Singh, J. Mechanisms of percutaneous absorption of tamoxifen by terpenes: Eugenol, d-limonene and menthone. J. Control. Rel. 1998, 55, 253-260.
52. Takahashi, K.; Sakano, H.; Yoshida, M.; Numata, N.; Mizuno, N. Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin. J. Control. Rel. 2001, 73, 351-358.
53. Fang, J.Y.; Hwang, T.L.; Leu, Y.L. Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int. J. Pharm. 2003, 250, 313-325.